ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
ONCOLYTICS BIOTECH INC
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Aug 12, 2026
$0.50−0.00 (-0.36%)
Close on Oct 19, 2026
Oncolytics Biotech statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Oncolytics Biotech | Industry median |
|---|---|---|
| Market Cap | C$90.30M | C$123.83M |
| Enterprise Value | C$90.30M | C$93.80M |
Efficiency
| Measure | Oncolytics Biotech | Industry median |
|---|---|---|
| Employee Count | 29 | 26 |
Shares
| Measure | Oncolytics Biotech | Industry median |
|---|---|---|
| Shares Outstanding | 127,511,000 | 74,643,400 |
| Shares Change (YoY) | 25.3% | 18.0% |
| Float | 125,140,000 | 74,292,200 |
| Shares Held by Insiders | 1.86% | 0.00% |
| Shares Held by Institutions | 3.09% | 9.14% |
Calculated by StockData from Oncolytics Biotech's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.